Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

GDDesign

  • Home
  • Author: GDDesign

Drug development companies in APAC need to raise their game to capitalise on the $33bn+ immuno-oncology treatment opportunity

Drug development companies in APAC need to raise their game to capitalise on the $33bn+ immuno-oncology treatment opportunity, says GlobalData Drug development companies in the APAC region have a huge opportunity to participate in the $33bn+ global immuno-oncology arena, observes GlobalData, a leading data and analytics company. According to the company’s recent PD-(L)1 combination pipeline […]
Read more

AI set to revolutionize retail banking, says GlobalData

For retail banks looking to differentiate themselves in an increasingly crowded marketplace, providing an enhanced digital customer experience is now an essential component of winning and retaining customers. The sector is increasingly looking to artificial intelligence (AI) to achieve this and is now on the cusp of a digital services revolution, with machine learning, natural language processing, and predictive analytics all set to turn retail banking into a data-driven industry.
Read more

Japan drug delivery devices market to touch $3.4bn by 2023

Japan’s drug delivery devices market, which was pegged at $2.56bn in 2016, is estimated to reach $3.4bn by 2023, says GlobalData, a recognized leader in providing business information and analytics. According to its latest report, the market is set to experience a CAGR of 4.2% during the forecast period. The report highlights the present conditions […]
Read more

APAC drug delivery devices market to reach $5.4 billion in 2023

Asia Pacific (APAC) region contributed 21% of global revenue in 2016 and the region is expected to witness higher growth compared to other regions. The company’s latest reveals that Japan will emerge as the major country in APAC region contributing 64% of the revenue in 2023. Japan contributed 62% of the revenue in the region […]
Read more

Sepsis & septic shock market to be worth $5.9 billion by 2026

The sepsis and septic shock space across the seven major pharmaceutical markets (7MM) of the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan is set to grow from $2.8 billion in 2016 to $5.9 billion by 2026, representing a compound annual growth rate (CAGR) of 7.9%, according to GlobalData, a recognized leader in providing business information and analytics.
Read more

Brexit woes for UK mortgage market as lending slows, says GlobalData

An analysis of the UK mortgage market by GlobalData, a recognized leader in providing business information and analytics, has confirmed that the market started to show signs of slowing down in 2016. Faced by the headwinds of Brexit and a slowing economy, GlobalData’s Global Retail Banking Analytics tool has revealed that while gross advances in H1 2016 were £22bn higher than during the same period in 2015, lending in H2 was flat year-on-year.
Read more

Retail finance to be fast tracked by S40m ZipMoney Investment

According to GlobalData, a recognized leader in providing business information and analytics, Westpac’s A$40m investment in ZipMoney could change the entire retail finance market in Australia. The deal heralds a step change in the provision of retail credit in Australia which will effectively provide consumers with a revolving line of unsecured credit at the point […]
Read more
1 2 3 4 5